Daniel Zelterman Selected Research

sotigalimab

1/2021

A Phase I Study of APX005M and Cabiralizumab with or without Nivolumab in Patients with Melanoma, Kidney Cancer, or Non-Small Cell Lung Cancer Resistant to Anti-PD-1/PD-L1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniel Zelterman Research Topics

Disease

24	Neoplasms (Cancer) 01/2021 - 11/2002
7	Breast Neoplasms (Breast Cancer) 02/2015 - 01/2005
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 12/2005
4	Melanoma (Melanoma, Malignant) 01/2021 - 01/2019
4	Lung Neoplasms (Lung Cancer) 10/2019 - 10/2008
4	Papilloma (Papillomatosis) 12/2010 - 08/2002
3	Genomic Instability 01/2018 - 04/2011
3	Carcinogenesis 01/2018 - 03/2010
3	Infections 05/2014 - 06/2007
3	HIV Infections (HIV Infection) 01/2012 - 02/2002
2	Fatigue 01/2021 - 06/2015
2	Disease Progression 01/2021 - 02/2015
2	Inflammation (Inflammations) 01/2018 - 07/2005
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 05/2014 - 08/2002
2	Ovarian Neoplasms (Ovarian Cancer) 01/2012 - 08/2010
2	Vesicular Stomatitis 12/2010 - 06/2007
2	Papillomavirus Infections 06/2007 - 08/2002
1	Edema (Dropsy) 01/2021
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2021
1	Kidney Neoplasms (Kidney Cancer) 01/2021
1	Adenocarcinoma of Lung 11/2019
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2019
1	Ischemic Stroke 01/2019
1	Memory Disorders (Memory Loss) 01/2019
1	Paraproteinemias (Monoclonal Gammopathy) 01/2017
1	Human Influenza (Influenza) 01/2017
1	Neutropenia 06/2015
1	Hypoxia (Hypoxemia) 06/2015
1	Pericardial Effusion 06/2015
1	Leukopenia 06/2015
1	Dyspnea (Shortness of Breath) 06/2015
1	Uterine Cervical Dysplasia 05/2014
1	Extensively Drug-Resistant Tuberculosis 01/2012
1	Triple Negative Breast Neoplasms 04/2011
1	Atrophy 03/2010
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 03/2010
1	Colitis 03/2010
1	Splenomegaly 03/2010
1	Gallbladder Neoplasms (Gallbladder Cancer) 09/2008
1	Leiomyoma (Uterine Fibroids) 05/2008

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 01/2019 - 12/2003
6	Biomarkers (Surrogate Marker)IBA 01/2019 - 01/2011
6	MicroRNAs (MicroRNA)IBA 01/2015 - 10/2008
5	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 07/2006
5	Genetic Markers (Genetic Marker)IBA 01/2012 - 10/2008
3	Pharmaceutical PreparationsIBA 01/2021 - 02/2002
3	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2018
3	Sirolimus (Rapamycin)FDA Link 01/2019 - 02/2015
3	Paclitaxel (Taxol)FDA LinkGeneric 09/2007 - 01/2005
2	Tyrosine Kinase InhibitorsIBA 11/2019 - 10/2019
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 11/2019 - 10/2019
2	DNA Polymerase beta (DNA Polymerase IV)IBA 01/2017 - 04/2011
2	Cisplatin (Platino)FDA LinkGeneric 01/2017 - 11/2002
2	TOR Serine-Threonine KinasesIBA 06/2015 - 02/2015
2	Messenger RNA (mRNA)IBA 04/2011 - 07/2007
2	3' Untranslated Regions (3' UTR)IBA 01/2011 - 10/2008
2	Capecitabine (Xeloda)FDA Link 02/2008 - 07/2007
2	Fluorouracil (Carac)FDA LinkGeneric 02/2008 - 07/2007
2	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2007 - 01/2005
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2007 - 01/2005
2	VaccinesIBA 06/2007 - 08/2002
2	Irinotecan (Camptosar)FDA LinkGeneric 12/2005 - 11/2002
2	Illicit Drugs (Recreational Drugs)IBA 09/2003 - 02/2002
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021
1	Creatine Kinase (Creatine Phosphokinase)IBA 01/2021
1	Alanine Transaminase (SGPT)IBA 01/2021
1	NivolumabIBA 01/2021
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2021
1	cabiralizumabIBA 01/2021
1	sotigalimabIBA 01/2021
1	Glyphosate (Roundup)IBA 01/2020
1	ErbB Receptors (EGF Receptor)IBA 10/2019
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2019
1	Methotrexate (Mexate)FDA LinkGeneric 01/2019
1	Cytidine Diphosphate Choline (Citicoline)IBA 01/2019
1	Circulating Tumor DNAIBA 01/2018
1	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2017
1	Albumin-Bound Paclitaxel FDA Link 06/2015
1	Dihydrotachysterol (AT 10)IBA 06/2015
1	Trastuzumab (Herceptin)FDA Link 02/2015
1	Estrogens (Estrogen)FDA Link 01/2015
1	hydrogen sulfite (bisulfite)IBA 05/2014
1	EnzymesIBA 07/2012
1	DNA-Directed DNA Polymerase (Polymerases, DNA)IBA 07/2012
1	Methyl MethanesulfonateIBA 07/2012
1	Biological ProductsIBA 04/2011
1	Progesterone Receptors (Progesterone Receptor)IBA 04/2011
1	Phenobarbital (Luminal)FDA Link 04/2011
1	Recombinant DNA (Recombinant DNA Research)IBA 12/2010
1	Interleukin-17 (Interleukin 17)IBA 03/2010
1	Polyvinyl AlcoholIBA 05/2008
1	GadoliniumIBA 05/2008
1	trisacryl gelatin microspheresIBA 05/2008

Therapy/Procedure

13	Therapeutics 01/2021 - 01/2005
6	Immunotherapy 01/2021 - 12/2003
3	Drug Therapy (Chemotherapy) 01/2017 - 02/2003
3	Radiotherapy 09/2008 - 07/2006
1	Stem Cell Transplantation 01/2019
1	Uterine Artery Embolization 05/2008